Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

NCT05428176

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • University of Calif San Francisco San Francisco, California, United States
View Trial Details
Active, Not Recruiting

Study of Lacutamab in Peripheral T-cell Lymphoma

NCT04984837

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • VZW ZAS Antwerp, Belgium
  • A. Z. Sint-Jan Bruges, Belgium
  • Cliniques Universitaires de Bruxelles - Hôpital Erasme Brussels, Belgium
View all 64 locations
View Trial Details
Active, Not Recruiting

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

NCT03960840

Conditions
Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +23 more
Locations
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Uni of Chi Medi Ctr Hema and Onco Chicago, Illinois, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies

NCT05207670

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

NCT01415752

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 418 locations
View Trial Details
Active, Not Recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

NCT02101853

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 186 locations
View Trial Details

Related conditions